BROOKE JONES: Open Payments
NPI 1821712522 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,620 in 55 payments from 19 companies in 2025. Trend: 2023 $588 · 2024 $2,007 · 2025 $3,620
Travel & lodging: $1,472Food & beverage: $1,448Consulting: $700
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $1,983 |
| Botanix SB Inc | 2 | $712 |
| Novartis Pharmaceuticals Corporation | 7 | $162 |
| Gilead Sciences, Inc. | 3 | $137 |
| Novo Nordisk Inc | 7 | $130 |
| ABBVIE INC. | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| LEO Pharma Inc. | 2 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $33 |
Products named: Bimzelx, SOFDRA, REXULTI, Descovy, XOLAIR, Ozempic, Rhapsido, ANZUPGO.
Industry payments across NC — which companies pay providers there.
